Clinical Trial

External Oblique Intercostal Block (EOICB) for Laparoscopic Cholecystectomy

Recruiting
View on ClinicalTrials.gov →
Summary
This single-center, prospective, randomized controlled trial aims to compare the effects of paravertebral block (PVB), external oblique intercostal (EOI) block, and intravenous patient-controlled analgesia (PCA) with tramadol on postoperative pain and opioid consumption in patients undergoing elective laparoscopic cholecystectomy. The primary endpoint is total tramadol consumption within 24 hours postoperatively. Secondary outcomes include pain scores, additional analgesic use, incidence of nausea/vomiting, mobilization time, and length of hospital stay.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-11-17; most recent amendment 2026-06-30.
Status change: Not Yet Recruiting → Recruiting 2026-05-10
Trial Details
NCT Number NCT07241949
Lead Sponsor Cukurova University
Conditions Postoperative Pain, Laparoscopic Cholecystectomy, Paravertebral Block, External Oblique Intercostal Plane Block, Patient Controlled Analgesia
Enrollment 147 participants
Start Date 2025-12-01
Primary Completion 2026-11-01 (estimated)
Study Completion 2026-12-05 (estimated)
Updated on ClinicalTrials.gov 2026-07-02